Screening for HIV-related neurocognitive impairment in clinical practice: Challenges and opportunities

References

• Al-Khindi, T., Zakzanis, K. K., & van Gorp, W. G. (2011). Does antiretroviral therapy improve HIV associated cognitive impairment? A quantitative review of the literature. Journal of the International Neuropsychological Society, 17(6), 956–969. doi:10.1017/S1355617711000968
   PubMed Web of Science ®Google Scholar
• American Medical Association. (2001). Practical guide for the primary care physician on the diagnosis, management and treatment of dementia. Chicago, IL: Program on Aging and Community Health.
   Google Scholar
• Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., … Wojna, V. E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b
   PubMed Web of Science ®Google Scholar
• Basso, M. R., Bornstein, R. A., & Lang, J. M. (1999). Practice effects on commonly used measures of executive function across twelve months. The Clinical Neuropsychologist, 13(3), 283–292. doi:10.1076/clin.13.3.283.1743
   PubMed Web of Science ®Google Scholar
• Basso, M. R., Carona, F. D., Lowery, N., & Axelrod, B. N. (2002). Practice effects on the WAIS-III across 3- and 6-month intervals. The Clinical Neuropsychologist, 16(1), 57–63. doi:10.1076/clin.16.1.57.8329
   PubMed Web of Science ®Google Scholar
• Becker, J. T., Dew, M. A., Aizenstein, H. J., Lopez, O. L., Morrow, L., & Saxton, J. (2011). Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care and STDs, 25(6), 351–3577. doi:10.1089/apc.2011.0051
   PubMed Web of Science ®Google Scholar
• Becker, J. T., Lopez, O. L., Dew, M. A., & Aizenstein, H. J. (2004). Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS, 1, S11–S18. Retrieved from http://www.psychology.pitt.edu/research/publications/becker_2004.pdf
   Google Scholar
• Beglinger, L. J., Gaydos, B., Tangphao-Daniels, O., Duff, K., Kareken, D. A., Crawford, J., Fastenau, P. S., & Siemers, E. R. (2005). Practice effects and the use of alternate forms in serial neuropsychological testing. Archives of Clinical Neuropsychology, 20(4), 517–529. doi:10.1016/j.acn.2004.12.003
   PubMed Web of Science ®Google Scholar
• Berghuis, J. P., Uldall, K. K., & Lalonde, B. (1999). Validity of two scales in identifying HIV associated dementia. Journal of Acquired Immune Deficiency Syndromes, 21, 134–140. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10360805
   PubMed Web of Science ®Google Scholar
• Bhaskaran, K., Mussini, C., Antinori, A., Walker, A. S., Dorrucci, M., Sabin, C., … Porter, K. (2008). Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Annals of Neurology, 63(2), 213–221. doi:10.1002/ana.21225
   PubMed Web of Science ®Google Scholar
• BHIVA. (2012). British HIV Association Guidelines. Retrieved from http://www.bhiva.org/documents/Guidelines/Treatment/2012/120430TreatmentGuidelines.pdf
   Google Scholar
• Bonnet, F., Amieva, H., Marquant, F., Bernard, C., Bruyand, M., Dauchy, F.-A., … Chêne, G. (2013). Cognitive disorders in HIV-infected patients: Are they HIV-related? AIDS, 27(3), 391–400. doi:10.1097/QAD.0b013e32835b1019
   PubMed Web of Science ®Google Scholar
• Brodt, H. R., Kamps, B. S., Gute, P., Knupp, B., Staszewski, S., & Helm, E. B. (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS, 11(14), 1731–1738. doi:10.1097/00002030-199714000-00010
   PubMed Web of Science ®Google Scholar
• Byrd, D. A., Fellows, R. P., Morgello, S., Franklin, D., Heaton, R. K., Deutsch, R., … Grant, I. (2011). Neurocognitive impact of substance use in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 58(2), 154–162. doi:10.1097/QAI.0b013e318229ba41
   PubMed Web of Science ®Google Scholar
• Canestri, A., Lescure, F.-X., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A., … Katlama, C. (2010). Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clinical Infectious Diseases, 50(5), 773–778. doi:10.1086/650538
   PubMed Web of Science ®Google Scholar
• Cinque. (2012, May). Screening for neurocognitive impairment: A practical approach. 5th International Symposium on Neuropsychiatry HIV Barcelona, Spain.
   Google Scholar
• Coughlan, A. K., & Hollows, S. E. (1985). The adult memory and information processing battery. Leeds: Psychology Department, St James' Hospital.
   Google Scholar
• Cysique, L. A., Maruff, P., Darby, D., & Brew, B. (2006). The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Archives of Clinical Neuropsychology, 21(2), 185–194. doi:10.1016/j.acn.2005.07.011
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Murray, J. M., Dunbar, M., Jeyakumar, V., & Brew, B. J. (2010). A screening algorithm for HIV-associated neurocognitive disorders. HIV Medicine, 11(10), 642–649. doi:10.1111/j.1468-1293.2010.00834.x
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., … Ellis, R. J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342–348. doi:10.1212/WNL.0b013e3181ab2b3b
   PubMed Web of Science ®Google Scholar
• Dore, G. J., McDonald, A., Li, Y., Kaldor, J. M., & Brew, B. J. (2003). National HIV Surveillance Committee. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 17(10), 1539–1545. doi:10.1097/00002030-200307040-00015
   PubMed Web of Science ®Google Scholar
• EACS. (2011). European AIDS Clinical Society Guidelines 2012. Retrieved from http://www.europeanaidsclinicalsociety.org/index.php?option=com_content&view=article&id=59&Itemid=41
   Google Scholar
• Ellis, R. J., Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., Clifford, D., … Grant, I. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS, 25(14), 1747–1751. doi:10.1097/QAD.0b013e32834a40cd
   PubMed Web of Science ®Google Scholar
• Ellis, R. J., Evans, S. R., Clifford, D. B., Moo, L. R., Mcarthur, J. C., Collier, A. C., … Robertson, K. (2005). Clinical validation of the NeuroScreen. Journal of Neurovirology, 11(6), 503–511. doi:10.1080/13550280500384966
   PubMed Web of Science ®Google Scholar
• Falleti, M. G., Maruff, P., Collie, A., & Darby, D. G. (2006). Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. Journal of Clinical and Experimental Neuropsychology, 28(7), 1095–1112. doi:10.1080/13803390500205718
   PubMed Web of Science ®Google Scholar
• Ganasen, K. A., Fincham, D., Smit, J., Seedat, S., & Stein, D. (2008). Utility of the HIV dementia Scale (HDS) in identifying HIV dementia in a South African sample. Journal of the Neurological Sciences, 269(1–2), 62–64. doi:10.1016/j.jns.2007.12.027
   PubMed Web of Science ®Google Scholar
• Garvey, L., Winston, A., Walsh, J., Post, F., Porter, K., Gazzard, B., … Sabin, C. A. (2011). Antiretroviral therapy CNS penetration and HIV-1 associated CNS disease. Neurology, 76(8), 693–700. doi:10.1212/WNL.0b013e31820d8b0b
   PubMed Web of Science ®Google Scholar
• Gisslén, M., Price, R. W., & Nilsson, S. (2011). The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence? BMC Infectious Diseases, 11(1), 356. doi:10.1186/1471-2334-11-356
   PubMed Web of Science ®Google Scholar
• González-Scarano, F., & Martín-García, J. (2005). The neuropathogenesis of AIDS. Nature Reviews Immunology, 5(1), 69–81. doi:10.1038/nri1527
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., … Grant, I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology, 75(23), 2087–2096. doi:10.1212/WNL.0b013e318200d727
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., … HNRC Group. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317–331.
   PubMed Web of Science ®Google Scholar
• Knippels, H. M. A., Goodkin, K., Weiss, J. J., Wilkie, F. L., & Antoni, M. H. (2002). The importance of cognitive self-report in early HIV-1 infection: Validation of a cognitive functional status subscale. AIDS, 16(2), 259–267. doi:10.1097/00002030-200201250-00016
   PubMed Web of Science ®Google Scholar
• Koski, L., Brouillette, M.-J., Lalonde, R., Hello, B., Wong, E., Tsuchida, A., & Fellows, L. (2011). Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment: Measuring cognition in HIV-infected individuals. HIV Medicine, 12(8), 472–480. doi:10.1111/j.1468-1293.2010.00910.x
   PubMed Web of Science ®Google Scholar
• Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment. New York, NY: Oxford University Press.
   Google Scholar
• Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical Care, 46(3), 266–274. doi:10.1097/MLR.0b013e318160d093
   PubMed Web of Science ®Google Scholar
• Martin, A., Rief, W., Klaiberg, A., & Braehler, E. (2006). Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. General Hospital Psychiatry, 28(1), 71–77. doi:10.1016/j.genhosppsych.2005.07.003
   PubMed Web of Science ®Google Scholar
• McCombe, J., Vivithanaporn, P., Gill, M., & Power, C. (2013). Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Medicine, 14(2), 99–107. doi:10.1111/j.1468-1293.2012.01043.x
   PubMed Web of Science ®Google Scholar
• Medfash. (2011). Standards for psychological support for adults living with HIV in the UK Joint publication of Medical Foundation for AIDS and Sexual Health, British HIV Association and British Psychological Society. Retrieved from http://www.medfash.org.uk/publications/documents/standards_for_psychological_support_for_adults_living_with_HIV.pdf
   Google Scholar
• Milne, A. (2010). Dementia screening and early diagnosis: The case for and against. Health, Risk and Society, 12(1), 65–76. doi:10.1080/13698570903509497
   Web of Science ®Google Scholar
• Morgan, E. E., Woods, S. P., Scott, J. C., Childers, M., Marquie Beck, J., Ellis, R. J., … Heaton, R. K. (2008). Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. Journal of Clinical and Experimental Neuropsychology, 30(1), 83–90. doi:10.100/13803390701233865
   PubMed Web of Science ®Google Scholar
• Mothobi, N. Z., & Brew, B. J. (2012). Neurocognitive dysfunction in the highly active antiretroviral therapy era. Current Opinion in Infectious Diseases, 25(1), 4–9. doi:10.1097/QCO.0b013e32834ef586
   PubMed Web of Science ®Google Scholar
• Nguyen, A., Calmy, A., Delhumeau, C., Mercier, I., Cavassini, M., Mello, A. F., … Hirschel, B. (2011). A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study). AIDS, 25(12), 1481–1487. doi:10.1097/QAD.0b013e328348dab0
   PubMed Web of Science ®Google Scholar
• Overton, E., Ances, B., Grubb, J., et al. (2011). Novel screening tools for HIV-associated neurocognitive disorders 18th CROI Paper 401.
   Google Scholar
• Perez-Valero, I., Bayon, C., Cambron, I., Gonzalez, A., Arribas, J. R. (2011). Protease inhibitor monotherapy and the CNS: Peace of mind? Journal of Antimicrobial Chemotheraphy, 66(9), 1954–1962. doi:10.1093/jac/dkr229
   PubMed Web of Science ®Google Scholar
• Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & Dekosky, S. T. (2001). Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56(9), 1133–1142. doi:10.1212/WNL.56.9.1133
   PubMed Web of Science ®Google Scholar
• Power, C., Selnes, O. A., Grim, J. A., & McArthur, J. C. (1995). HIV dementia scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8(3), 273–278. doi:10.1097/00042560-199503010-00008
   PubMedGoogle Scholar
• Price, R., & Brew, B. (1988). The AIDS dementia complex. Journal of Infectious Diseases, 158(5), 1079–1083. doi:10.1093/infdis/158.5.1079
   PubMed Web of Science ®Google Scholar
• Royle, J., & Lincoln, N. B. (2008). The everyday memory questionnaire-revised: Development of a 13-item scale. Disability and Rehabilitation, 30(2), 114–121. doi:10.1080/09638280701223876
   PubMed Web of Science ®Google Scholar
• Sacktor, N., Haughey, N., Cutler, R., Tamara, A., Turchan, J., Pardo, C., … Nath, A. (2004). Novel markers of oxidative stress in actively progressive HIV dementia. Journal of Neuroimmunology, 157(1–2), 176–184. doi:10.1016/.jneuroim.2004.08.037
   PubMedGoogle Scholar
• Simioni, S., Cavassini, M., Annoni, J. M., Rimbault, A. A., Bourquin, I., Schiffer, V., … Du Pasquier, R. A. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viraemia. AIDS, 24, 1243–1250. doi:10.1097/QAD.0b013e3283354a7b
   PubMed Web of Science ®Google Scholar
• Skinner, S., Adewale, A., DeBlock, L., Gill, M., & Power, C. (2009). Neurocognitive screening tools in HIV/AIDS: Comparative performance among patients exposed to antiretroviral therapy. HIV Medicine, 10(4), 246–252. doi:10.1111/j.1468-1293.2008.00679.x
   PubMed Web of Science ®Google Scholar
• Thames, A. D., Kim, M. S., Becker, B. W., Foley, J. M., Hines, L. J., Singer, E. J., … Hinkin, C. H. (2011). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical and Experimental Neuropsychology, 33(2), 200–209. doi:10.1080/13803395.2010.499357
   PubMed Web of Science ®Google Scholar
• U.S. Preventive Services Task Force. (2003). Screening for dementia: Recommendation and rationale. Annals of Internal Medicine, 138(11), 925–926. doi:10.7326/0003-4819-138-11-200306030-00014
   PubMedGoogle Scholar
• Valcour, V. G. (2011). Evaluating cognitive impairment in the clinical setting: Practical screening and assessment tools top. Antiviral Medicine, 19, 175–180.
   PubMedGoogle Scholar
• Valcour, V., Paul, R., Chiao, S., Wendelken, L. A., & Miller, B. (2011). Screening for cognitive impairment in Human Immunodeficiency Virus. Clinical Infectious Diseases, 53(8), 836–842. doi:10.1093/cid/cir524
   PubMed Web of Science ®Google Scholar
• Vivithanaporn, P., Nelles, K., DeBlock, L., Newman, S. C., Gill, M. J., & Power, C. (2012). Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. Journal of the Neurological Sciences, 312(1–2), 45–51. doi:10.1016/j.jns.2011.08.025
   PubMed Web of Science ®Google Scholar
• Ward, D. J., & Curtin, J. M. (2006). Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles. AIDS Patient Care and STDs, 20(8), 542–548. doi:10.1089/apc.2006.20.542
   PubMed Web of Science ®Google Scholar
• Waters, L., Fisher, M., Winston, A., Higgs, C., Hadley, W., Garvey, L., … Nelson, M. (2011). A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine. AIDS, 25(1), 65–71. doi:10.1097/QAD.0b013e32834168b
   PubMed Web of Science ®Google Scholar
• Winston, A., Arenas-Pinto, A., Stoehr, W., Fisher, M., Orkin, C., Aderogba, K., … PIVOT Trial Team. (2011). Factors influencing neurocognitive function in a large cohort of HIV infected patients on effective antiretroviral therapy. 13th EACS 2011 Abstract PS2/4.
   Google Scholar
• Winston, A. (2012, May). Asymptomatic NCI: Illusion or reality? 5th International Symposium on Neuropsychiatry HIV Barcelona, Spain.
   Google Scholar
• Winston, A., Puls, R., Kerr, S. J., Duncombe, C. J., Li, P. C. K., Gill, J. M., … Cooper, D. A. (2012). Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: A randomized, controlled study. HIV Medicine, 13, 245–251.
   PubMed Web of Science ®Google Scholar